Ann Arbor


ANN ARBOR, Mich. - Aastrom Biosciences Inc., which develops stem cell therapies, said Wednesday it received a notice saying it might be subject to delisting from the Nasdaq.
Older News
S M T W T F S
-4 -3 -2 -1 0 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
Copyright© 2010 The Gaea Times